Stay updated with breaking news from Nasdaq Podd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insulet (NASDAQ:PODD – Get Free Report) had its price target reduced by equities researchers at Barclays from $329.00 to $257.00 in a note issued to investors on Thursday, MarketBeat.com reports. The firm presently has an “equal weight” rating on the medical instruments supplier’s stock. Barclays‘s price objective points to a potential upside of 14.08% from […]
Insulet (NASDAQ:PODD – Free Report) had its price target decreased by Wells Fargo & Company from $375.00 to $330.00 in a research note issued to investors on Wednesday morning, FlyOnTheWall reports. A number of other research firms have also weighed in on PODD. UBS Group raised their target price on Insulet from $328.00 to $360.00 […]
Insulet Co. (NASDAQ:PODD – Get Free Report)’s stock price fell 8.4% during trading on Tuesday . The stock traded as low as $238.16 and last traded at $238.85. 1,466,170 shares changed hands during trading, an increase of 119% from the average session volume of 669,609 shares. The stock had previously closed at $260.85. Analyst Upgrades […]
Artemis Investment Management LLP decreased its holdings in Insulet Co. (NASDAQ:PODD – Free Report) by 9.7% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,006 shares of the medical instruments supplier’s stock after selling 537 shares during the quarter. Artemis Investment Management LLP’s […]
Virtu Financial LLC purchased a new stake in Insulet Co. (NASDAQ:PODD – Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 2,500 shares of the medical instruments supplier’s stock, valued at approximately $797,000. Other institutional investors and hedge funds have also recently […]